Medical News

RSS

Kane Biotech increases current private placement offering from 3,846,154 units to 4,335,500 units

Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, today announces that it has increased the current private placement offering (the "Offering"), first reported on November 16, 2009, from a maximum of 3,846,154 units to 4,335,500 Units, for total gross proceeds of up to $563,615.

27 Nov 2009

Third-quarter 2009 financial results announced by Chai-Na-Ta

Chai-Na-Ta Corp., one of the world's largest suppliers of North American ginseng, today announced a third quarter 2009 net loss of $136,000, or less than $0.01 per basic share, compared to a net loss of $2.0 million, or $0.06 per basic share, in the same period last year.

27 Nov 2009

Medipattern revenues declines to $2,119 in the first quarter of fiscal 2010

The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, today announced its business highlights and unaudited financial results for the first quarter of fiscal 2010 ended September 30, 2009.

27 Nov 2009

Cannasat Therapeutics reports net loss of $336,154 for the three months ended September 30, 2009

Cannasat Therapeutics Inc., a clinical stage pharmaceutical company developing products to treat neurological disorders, today announced its results for the nine months ended September 30, 2009. Unless specified otherwise, all amounts are in Canadian dollars.

27 Nov 2009

Aptilon revenues up $3.71 million in third quarter 2009

Aptilon Corporation, a leader in online marketing to physicians and healthcare professionals, today announced its financial results for the three and nine months ended September 30, 2009. Financial references are in CDN dollars unless otherwise indicated. Complete financial statements and MD&A are available on SEDAR at www.sedar.com.

27 Nov 2009

Many amendments to massive Senate health bill expected

The Senate is scheduled to begin debate Monday on health care, and according to some news organizations, they have their work cut out for themselves.

27 Nov 2009

Dems face huge challenge in reconciling abortion language in House, Senate health bills

Several news outlets are following the dilemmas that Democrats are facing in the health reform bills due to abortion.

27 Nov 2009

Rights Issue to be carried out by keeping the authorization by the Annual General Meeting, resolves Tripep

The Board of Directors of Tripep AB (publhas on the 27th of November 2009, based on the authorization by the Annual General Meeting resolved to carry out a rights issue.

27 Nov 2009

Tripep completes clinical trial of ChronVac-C for Hepatitis C virus treatment

All samples from the 12 patients with chronic Hepatitis C genotype 1 treated with Tripep’s therapeutic vaccine ChronVac-C have now been collected. The treatment was found to be safe, immunogenic and had transient effects on the serum levels of hepatitis C virus.

27 Nov 2009

Study examines fundamental aspects of fertility in yeast

Research at the University of Leicester analyzing common Baking and Brewers yeast is providing new insights into aspects of human health and fertility.

27 Nov 2009

Stallergenes granted European approval to market Oralair

Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair(R) has been marketed, was the reference Member state.

27 Nov 2009

European Commission approves MICARDIS medication for CV protection

MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.

27 Nov 2009

iCo Therapeutics reports financial results for three months ended September 30, 2009

iCo Therapeutics Inc. today reported financial results for the three months ended September 30, 2009. Amounts, unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP).

27 Nov 2009

School closure during infectious disease pandemic reduces illness transmission

A survey carried out in eight European countries has shown that closing schools in the event of an infectious disease pandemic could have a significant role in reducing illness transmission.

27 Nov 2009

Sectra and Fundación García Muñoz sign a partnership agreement

Sectra has signed a partnership agreement with the Spanish company Fundación García Muñoz S.L. Founded in 1920, Fundación García Muñoz is a leading supplier of medical equipment and has an extensive customer base in both the private and public healthcare sectors in Spain.

27 Nov 2009

Dr. Gail Harrison to receive the March of Dimes Agnes Higgins Award

A nutritionist whose research was instrumental in adding fruits and vegetables to the federal Women, Infants and Children (WIC) food subsidy will receive the March of Dimes Agnes Higgins Award for outstanding achievement in the field of maternal-fetal nutrition.

27 Nov 2009

Combination of CPR and AED saves boy's life

A 13-year old male student attending James Keating Elementary School is alive today thanks to the partnership between the Heart and Stroke Foundation of Ontario and the County of Simcoe Paramedic Services.

27 Nov 2009

B cells and their antibodies defend against microbes and control commensal microflora

Microbes populated the earth long before any eukariotic cell. Therefore, in order to survive, mono and multi-cellular organisms had to develop mechanisms of adaptation, cohabitation and defense against bacteria, fungi and viruses. One of these mechanisms is mediated by immunoglobulins in the serum and at mucosal surfaces.

27 Nov 2009

Advitech announces merger operations with Botaneco Specialty Ingredients

Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) announced today that, further to the consolidation of its common shares on a 8-for-1 basis (the "Consolidation"), the TSX Venture Exchange Inc. (the "TSX-V") has approved the release from escrow of the previously announced acquisition of all the issued and outstanding shares of Botaneco Specialty Ingredients Inc.

27 Nov 2009

Bobby Moore Fund launches 'Project South Africa' to raise critical funds for bowel cancer research

The Bobby Moore Fund for Cancer Research UK is offering up to 40 participants a travel experience with a difference to the beautiful Republic of South Africa, just months before the country hosts the World Cup.

27 Nov 2009